CRYOSITE LIMITED
ASX:CTEPharmaceuticals, Biotechnology & Life SciencesNo issuance filings since 2024; no dilution pressure signals in current disclosures
CRYOSITE LIMITED listed in May 2002 and its disclosure history spans back to that date. There are no share-issuance (Appendix 2A) filings on record in the window and no new share-issuance (Appendix 2A) filings lodged since January 2024. The company did not raise capital in the 24-month window reported. The company does not have a current quarterly cash report on record, so no quarterly cash balance or funding-runway figure is disclosed. There are no proposed securities issues (Appendix 3B) currently pending.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 3 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | Total on issue after | Source |
|---|---|---|---|---|
| 18 Mar 2026 | 3G · unquoted | ORDINARY FULLY PAID | 48.8M | Appendix 3G |
| 23 Oct 2025 | 3G · unquoted | CTE : ORDINARY FULLY PAID | 48.8M | Appendix 3G |
| 17 Mar 2025 | 3G · unquoted | CTE : ORDINARY FULLY PAID | 48.8M | Appendix 3G |
Capital raises
Pending proposed issues
Options & convertible securities
Director dealings
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.